These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 24169556
1. Perfluorooctanesulfonate (PFOS) perturbs male rat Sertoli cell blood-testis barrier function by affecting F-actin organization via p-FAK-Tyr(407): an in vitro study. Wan HT, Mruk DD, Wong CK, Cheng CY. Endocrinology; 2014 Jan; 155(1):249-62. PubMed ID: 24169556 [Abstract] [Full Text] [Related]
2. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Li N, Mruk DD, Chen H, Wong CK, Lee WM, Cheng CY. Sci Rep; 2016 Jul 20; 6():29667. PubMed ID: 27436542 [Abstract] [Full Text] [Related]
4. Focal adhesion kinase-Tyr407 and -Tyr397 exhibit antagonistic effects on blood-testis barrier dynamics in the rat. Lie PP, Mruk DD, Mok KW, Su L, Lee WM, Cheng CY. Proc Natl Acad Sci U S A; 2012 Jul 31; 109(31):12562-7. PubMed ID: 22797892 [Abstract] [Full Text] [Related]
5. Perfluorooctane sulfonate-induced Sertoli cell injury through c-Jun N-terminal kinase: a study by RNA-Seq. Gao S, Chen Z, Wu X, Wang L, Bu T, Li L, Li X, Yun D, Sun F, Cheng CY. Am J Physiol Cell Physiol; 2024 Aug 01; 327(2):C291-C309. PubMed ID: 38826136 [Abstract] [Full Text] [Related]
6. Fluorochloridone perturbs blood-testis barrier/Sertoli cell barrier function through Arp3-mediated F-actin disruption. Liu L, Zhang Y, Chang X, Li R, Wu C, Tang L, Zhou Z. Toxicol Lett; 2018 Oct 01; 295():277-287. PubMed ID: 29981920 [Abstract] [Full Text] [Related]
7. Perfluorooctane sulfonate (PFOS) disrupts blood-testis barrier by down-regulating junction proteins via p38 MAPK/ATF2/MMP9 signaling pathway. Qiu L, Qian Y, Liu Z, Wang C, Qu J, Wang X, Wang S. Toxicology; 2016 Dec 12; 373():1-12. PubMed ID: 27818224 [Abstract] [Full Text] [Related]
15. An occludin-focal adhesion kinase protein complex at the blood-testis barrier: a study using the cadmium model. Siu ER, Wong EW, Mruk DD, Sze KL, Porto CS, Cheng CY. Endocrinology; 2009 Jul 12; 150(7):3336-44. PubMed ID: 19213829 [Abstract] [Full Text] [Related]
16. Basement Membrane Laminin α2 Regulation of BTB Dynamics via Its Effects on F-Actin and Microtubule Cytoskeletons Is Mediated Through mTORC1 Signaling. Gao Y, Chen H, Lui WY, Lee WM, Cheng CY. Endocrinology; 2017 Apr 01; 158(4):963-978. PubMed ID: 28323988 [Abstract] [Full Text] [Related]
17. rpS6 regulates blood-testis barrier dynamics through Arp3-mediated actin microfilament organization in rat sertoli cells. An in vitro study. Mok KW, Chen H, Lee WM, Cheng CY. Endocrinology; 2015 May 01; 156(5):1900-13. PubMed ID: 25714812 [Abstract] [Full Text] [Related]
19. P-glycoprotein regulates blood-testis barrier dynamics via its effects on the occludin/zonula occludens 1 (ZO-1) protein complex mediated by focal adhesion kinase (FAK). Su L, Mruk DD, Lui WY, Lee WM, Cheng CY. Proc Natl Acad Sci U S A; 2011 Dec 06; 108(49):19623-8. PubMed ID: 22106313 [Abstract] [Full Text] [Related]
20. CAMSAP2 Is a Microtubule Minus-End Targeting Protein That Regulates BTB Dynamics Through Cytoskeletal Organization. Mao BP, Li L, Ge R, Li C, Wong CKC, Silvestrini B, Lian Q, Cheng CY. Endocrinology; 2019 Jun 01; 160(6):1448-1467. PubMed ID: 30994903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]